<DOC>
	<DOCNO>NCT02298868</DOCNO>
	<brief_summary>The purpose study determine safety efficacy medication Baclofen treatment muscle cramp patient cirrhosis .</brief_summary>
	<brief_title>Safety Efficacy Baclofen Treatment Muscle Spasms Patients With Cirrhosis : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Muscle Cramp</mesh_term>
	<mesh_term>Spasm</mesh_term>
	<criteria>Cirrhosis Presence muscle cramp regular basis Allergy hypersensitivity Baclofen Active untreated Portosystemic encephalopathy Active alcohol substance abuse Age le 18 Pregnancy Concomitant use narcotic pain medication , muscle relaxer , antispastic agent Concomitant use Tricyclic Antidepressant due drug interaction History chronic kidney disease define GFR &lt; 30 ( use MDRD equation ) Subject institutionalized prisoner Inability unwillingness give informed consent Expected lifespan le 3 month Severe poorly control coexist medical condition significant issue determine principal investigator hinder ability adhere study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>